Mario Alberto Accardi Centessa Pharmaceuticals PLC (CNTA) insider trading activity

Mario Alberto Accardi is President, Orexin Program of Centessa Pharmaceuticals plc. Currently has a direct ownership of 178,801 shares of CNTA, which is worth approximately $4.94 Million. The most recent transaction as insider was on Dec 09, 2025, when has been sold 10,000 shares (Ordinary Shares) at a price of $28.96 per share, resulting in proceeds of $289,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 179K

9.42% 3M change

n/a 12M change

Total Value Held $4.94 Million

Mario Alberto Accardi Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 09 2025	SELL Open market or private sale	$289,600 $28.96 p/Share	10,000 Reduced 5.3%	178,801 Ordinary Shares
Dec 08 2025	SELL Open market or private sale	$300,000 $30.0 p/Share	10,000 Reduced 5.03%	188,801 Ordinary Shares
Dec 08 2025	BUY Exercise of conversion of derivative security	$47,650 $9.53 p/Share	5,000 Added 2.45%	198,801 Ordinary Shares
Nov 01 2025	SELL Payment of exercise price or tax liability	$14,765 $24.9 p/Share	593 Reduced 0.31%	193,801 Ordinary Shares
Oct 27 2025	SELL Open market or private sale	$200,000 $25.0 p/Share	8,000 Reduced 3.95%	194,394 Ordinary Shares
Oct 27 2025	BUY Exercise of conversion of derivative security	$40,050 $8.01 p/Share	5,000 Added 2.41%	202,394 Ordinary Shares
Sep 16 2025	SELL Open market or private sale	$177,168 $21.68 p/Share	8,172 Reduced 3.98%	197,394 Ordinary Shares

Sep 09 2025	SELL Open market or private sale	$140,000 $20.0 p/Share	7,000 Reduced 3.29%	205,566 Ordinary Shares
Sep 09 2025	BUY Exercise of conversion of derivative security	$40,050 $8.01 p/Share	5,000 Added 2.3%	212,566 Ordinary Shares
Aug 01 2025	SELL Payment of exercise price or tax liability	$10,250 $17.17 p/Share	597 Reduced 0.29%	207,566 Ordinary Shares
Jul 29 2025	SELL Open market or private sale	$126,744 $15.23 p/Share	8,322 Reduced 3.84%	208,163 Ordinary Shares
Jun 24 2025	SELL Open market or private sale	$210,000 $14.0 p/Share	15,000 Reduced 6.48%	216,485 Ordinary Shares
Jun 24 2025	BUY Exercise of conversion of derivative security	$57,750 $3.85 p/Share	15,000 Added 6.09%	231,485 Ordinary Shares

MAA

Mario Alberto Accardi

President, Orexin Program

Cheshire, X0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CNTA shares.

Notify only if

Value

Insider Trading

Get notified when an Centessa Pharmaceuticals PLC insider buys or sells CNTA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Centessa Pharmaceuticals plc

Track Activities on CNTA

Account